Mammoth Scientific Selects SS&C for Inaugural VC Fund
Innovative venture capital firm will leverage SS&C's fund administration services and Intralinks' InvestorVision for fund
Read More
MiRus Receives FDA 510(K) Clearance For The Lowest Profile and Best-in-class Expandable Lumbar Interbody
MiRus LLC, the leading innovator in rhenium-based superalloy medical implants announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its IO™ Expandable Lumbar Interbody.
Read More
U.S. Venture Capital Firm backs MRIguidance
Mammoth Scientific invests $1.25 Million in MRIguidance through its venture capital fund Mammoth Private Capital to enable further growth and prepare for market roll-out of BoneMRI in the U.S.
Read More
InvestmentNews - Venture capital firm targets RIAs
High-net-worth clients are interested in private investments, and Mammoth Scientific, which just rolled out a venture capital fund, aims to provide such products to the RIA channel, say two of its founders, Jud Mackrill and Tommy Martin.
Read More
NIIC Member, Mammoth VC Launches Fund
Mammoth™ Scientific, a health science and technology venture capital firm, announced the launch of a venture capital fund today.
Read More
MiRus™ Raises $65 Million For Expansion of Rhenium-based Medical Devices
MiRus LLC, a commercial stage life sciences company, has completed a highly oversubscribed funding round for growth of its spine and extremity portfolios and development of structural heart disease solutions using its proprietary Rhenium-based alloys (MoRe®). The round was led by Mammoth Scientific and multi-generational family offices who have supported MiRus from its inception.
Read More
RIA Intel: With a New Platform This VC Firm Aspires to Make the Asset Class More Accessible to RIAs
A top neurosurgeon, a cardiologist-turned-serial entrepreneur, and three high-profile wealth management executives have started a venture capital firm and are simultaneously developing a platform they say will transform the way RIAs build investment portfolios.
Read More